Guangxi Liuzhou Pharmaceutical Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Liuzhou Pharmaceutical Co Ltd with three other
companies in this sector in China:
Luyan Pharma Co Ltd
sales of 8.34 billion Chinese Renmimbi [US$1.23 billion]
of which 94%
was Pharmaceutical Wholesale),
Jiangsu Nhwa Pharmaceutical Company Limited
(3.39 billion Chinese Renmimbi [US$501.52 million]
of which 55%
was Medical Industrial Manufacturing), and
Cachet Pharmaceutical Company., Limited
(14.24 billion Chinese Renmimbi [US$2.10 billion]
of which 98%
was Medical Wholesale).
During the year ended December of 2017, sales at
Guangxi Liuzhou Pharmaceutical Co Ltd were 9.45 billion Chinese Renmimbi (US$1.40 billion).
increase of 25.0%
versus 2016, when the company's sales were 7.56 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guangxi Liuzhou Pharmaceutical Co Ltd
(and since 2012, sales have increased a total of 166%).
Sales of Other Business saw an increase
43.5% in 2017, from
8.66 million Chinese Renmimbi to 12.43 million Chinese Renmimbi.
Not all segments of Guangxi Liuzhou Pharmaceutical Co Ltd experienced an increase in sales in 2017:
sales of Other fell 59.3% to 1.37 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).